Stifel analyst Parker Lane maintains Adobe (NASDAQ:ADBE) with a Buy and lowers the price target from $500 to $375.
BioMarin Presents Data Highlighting Impact Of VOXZOGO In Bone Health And Health-Related Quality Of Life In Achondroplasia At 2024 ICCBH
New Investigator-Led Study Shows VOXZOGO Significantly Increased Bone Length While Maintaining Bone Strength Through 5 Years of Observation in Children with AchondroplasiaPhase 2 and 3 Data on VOXZOGO Demonstrate Safety,
